TD Ameritrade Investment Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
HL
TD Ameritrade Investment Management's GMAB Position: Q3 2023 in Review
TD Ameritrade Investment Management sold out of Genmab (GMAB) in Q3 2023, closing a stake of 2,254 shares — an estimated $86K sold.
TD Ameritrade Investment Management first reported a position in GMAB in Q3 2019 and held it in 16 quarters. The position peaked at $207K in Q4 2021. 233 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.
- TD Ameritrade Investment Management reported no remaining Genmab position as of Q3 2023 after selling out during the quarter.
- TD Ameritrade Investment Management sold 2,254 Genmab shares in Q3 2023, an estimated $86K.
- TD Ameritrade Investment Management first reported a position in Genmab in Q3 2019 and held it in 16 quarters.
- TD Ameritrade Investment Management's Genmab position peaked at $207K in Q4 2021.
- 233 funds tracked by Wall St. Rank held Genmab as of Q3 2023.
Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.